The use of a TLR2 agonist-based adjuvant for enhancing effector and memory CD8 T-cell responses.
about
Synthetic self-adjuvanting glycopeptide cancer vaccinesUniversal immunity to influenza must outwit immune evasionImmune Adjuvant Effect of Molecularly-defined Toll-Like Receptor LigandsInactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models.A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells populationThe Novel Toll-Like Receptor 2 Agonist SUP3 Enhances Antigen Presentation and T Cell Activation by Dendritic Cells.The basics and advances of immunomodulators and antigen presentation: a key to development of potent memory response against pathogens.Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells.Structure-function relationships of protein-lipopeptide complexes and influence on immunogenicity.Peptide Lipidation - A Synthetic Strategy to Afford Peptide Based Therapeutics.
P2860
Q26777837-07405483-818A-4989-8A0C-841B64F7E813Q26991896-CB05858B-A65C-4C76-A423-408A447E3380Q28972540-F9EED54B-4638-45F4-99C4-1FAAB2B7F11FQ36227268-DDAB3953-17FE-46DF-A9A2-8C3A8FE4FFD0Q36599857-008B8D15-3E9B-4389-8091-A521CC4F9A4AQ37327608-95A206DD-5DDF-45B9-BB9B-25918FF4EF01Q37653873-AEEFA9A9-FCFF-4487-AD1D-2586F14739E2Q38217630-A83A4169-2941-4C6C-BF67-9E39CA215AE3Q38717713-E628241E-1874-462D-BF4F-F28BA5286F82Q40130682-FF6E2704-0EE2-4F9E-B548-C6760681C147Q47590580-ECDD20E4-7709-45AB-95B5-EFB2C7FE10F7
P2860
The use of a TLR2 agonist-based adjuvant for enhancing effector and memory CD8 T-cell responses.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The use of a TLR2 agonist-base ...... d memory CD8 T-cell responses.
@en
The use of a TLR2 agonist-base ...... d memory CD8 T-cell responses.
@nl
type
label
The use of a TLR2 agonist-base ...... d memory CD8 T-cell responses.
@en
The use of a TLR2 agonist-base ...... d memory CD8 T-cell responses.
@nl
prefLabel
The use of a TLR2 agonist-base ...... d memory CD8 T-cell responses.
@en
The use of a TLR2 agonist-base ...... d memory CD8 T-cell responses.
@nl
P2860
P50
P356
P1476
The use of a TLR2 agonist-base ...... d memory CD8 T-cell responses.
@en
P2093
Chinn Y Wong
Toshiki Sekiya
P2860
P304
P356
10.1038/ICB.2013.102
P577
2014-01-07T00:00:00Z